In a recent multi-center study, Spanish researchers identified several immune system characteristics of multiple myeloma patients who have achieved long-term disease control.

They found that patients who achieve long-term disease control have a distinct immune system profile that differs from patients with active disease and from that of healthy adults.

This distinct profile, the researchers argue, likely plays a role in the patients achieving long-term control of their myeloma, and thus deserves further investigation.

The majority of multiple myeloma patients relapse within a median of three years from their initial diagnosis. However, …